GLP1 Medical Weight Loss

Are Ozempic, Wegovy, Mounjaro & Other GLP1 Weight Loss Meds Safe?

Few medical treatments have generated as much public conversation as GLP1 weight loss meds. With Ozempic, Wegovy, Mounjaro, and Zepbound transforming how doctors approach obesity and metabolic disease, many patients also wonder how safe these medications truly are. Are the headlines exaggerated, or are there real risks worth knowing about before starting treatment?

The good news is that GLP1 weight loss meds have been studied extensively in tens of thousands of patients and are FDA-approved for chronic weight management when used appropriately. At Goldenberg Dermatology in Manhattan, board-certified dermatologists Drs. Gary and Kristina Goldenberg take patient safety seriously, prescribing these medications only after a thorough medical review and supervising care closely throughout treatment.

How GLP1 Weight Loss Meds Affect the Body

GLP1 weight loss meds work by mimicking a natural hormone called glucagon-like peptide 1, which the gut releases after eating. This hormone influences several systems at once, including appetite, blood sugar regulation, and the speed at which food moves through the stomach.

By activating GLP1 receptors, these medications help reduce hunger, prolong feelings of fullness, and improve insulin sensitivity. The combined effect supports gradual weight loss while also benefiting overall metabolic health.

At Goldenberg Dermatology in Manhattan, our board-certified dermatologists explain exactly how GLP1 weight loss meds influence these bodily systems so patients understand both the benefits and the adjustments their bodies will go through.

Common Side Effects of GLP1 Weight Loss Meds

The most frequently reported side effects of GLP1 weight loss meds are gastrointestinal in nature. Nausea, mild stomach pain, constipation, diarrhea, and occasional indigestion can occur, especially during the first few weeks of treatment or after a dose increase.

These reactions tend to be mild and short-lived for most patients. Eating smaller meals, avoiding fried or very rich foods, and drinking plenty of water often help reduce discomfort while the body adjusts to the medication.

Our Manhattan medical weight loss team starts patients at a low introductory dose and titrates slowly, which significantly reduces the chance of bothersome side effects from GLP1 weight loss meds.

Rare Risks Associated with GLP1 Weight Loss Meds

Beyond the common digestive issues, certain rare risks have been identified in clinical research. Pancreatitis, gallbladder problems, and severe dehydration from prolonged vomiting have been reported in a small percentage of users, according to data summarized by the National Institutes of Health.

Animal studies also linked GLP1 receptor agonists to thyroid C-cell tumors, although this finding has not been clearly demonstrated in humans. Out of caution, the medications carry a warning regarding medullary thyroid carcinoma.

Top Manhattan dermatologists Drs. Gary and Kristina Goldenberg review every patient’s medical history thoroughly before prescribing GLP1 weight loss meds to identify and avoid these rare but important risks.

Who Should Avoid GLP1 Weight Loss Meds

Certain individuals are not candidates for GLP1 weight loss meds. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not take these medications under any circumstances.

A history of pancreatitis, severe gastroparesis, certain gallbladder conditions, pregnancy, or breastfeeding can also make these medications inappropriate. Patients with active eating disorders may need alternative treatment approaches as well.

At Goldenberg Dermatology in Manhattan, our team conducts a careful medical screening to confirm that GLP1 weight loss meds are safe and suitable before any prescription is written.

How Doctors Monitor Patients on GLP1 Weight Loss Meds

Ongoing monitoring is one of the most important parts of safe treatment with GLP1 weight loss meds. Patients are typically seen at regular intervals to assess weight changes, side effects, blood pressure, and any new symptoms that may arise during treatment.

Lab work may also be ordered periodically to track blood sugar, kidney function, and other health markers depending on the patient’s history. These check-ins also offer the chance to adjust the dose or troubleshoot any concerns.

Our Manhattan medical weight loss program builds in routine follow-ups and clear communication so patients on GLP1 weight loss meds always have professional support available.

Long-Term Safety of GLP1 Weight Loss Meds

Long-term studies, including the SELECT trial reviewed in The New England Journal of Medicine, have followed patients on GLP1 weight loss meds for several years and found that the medications continue to be well tolerated, with no major new safety concerns emerging over time.

Some research even suggests benefits beyond weight loss, including reduced risk of cardiovascular events in adults with obesity and existing heart disease. Continued lifestyle support remains important for keeping results stable for the long haul.

Drs. Gary and Kristina Goldenberg follow updated safety research closely and apply the latest evidence-based protocols when supervising patients on GLP1 weight loss meds.

Am I a Good Candidate for GLP1 Weight Loss Meds?

Determining whether someone is a good candidate involves more than meeting a BMI cutoff. Medical history, current medications, lifestyle, and personal goals all factor into the decision. A face-to-face evaluation is the only reliable way to find out.

Adults who have struggled with weight despite consistent effort, who have weight-related health conditions, and who are committed to ongoing supervised care are typically the best candidates for GLP1 weight loss meds.

At Goldenberg Dermatology in Manhattan, our board-certified dermatologists perform a thorough evaluation at the first visit to determine candidacy and design a personalized GLP1 weight loss meds plan when appropriate.

GLP1 Weight Loss Meds | Manhattan

Schedule a GLP1 Weight Loss Meds Appointment

If you live in Manhattan and you have questions about whether GLP1 weight loss meds are safe and right for you, our team at Goldenberg Dermatology is ready to help. Drs. Gary and Kristina Goldenberg will give you straightforward answers, careful evaluation, and a customized plan for your weight loss journey. Schedule an appointment today to take the next step toward safer, healthier weight management.

Manhattan GLP1 Weight Loss Medication: 212-405-8202